CompletedPhase 2NCT00128180
Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
Studying Hantavirus pulmonary syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of New Mexico
- Principal Investigator
- Pablo Vial, MDUniversidad del Desarrollo
- Intervention
- Methylprednisolone(drug)
- Enrollment
- 66 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2003 – 2011
Study locations (1)
- Facultad de Medicina Clinica Alemana- Universidad del Desarrollo, Santiago, Chile
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00128180 on ClinicalTrials.govOther trials for Hantavirus pulmonary syndrome
Additional recruiting or active studies for the same condition.